The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
ALDH2 protein results in increased metabolism of benzaldehyde benzaldehyde inhibits the reaction [4-dimethylaminocinnamaldehyde binds to ALDH2 protein]
[ALDH3A1 protein co-treated with NAD] results in increased oxidation of benzaldehyde; [ALDH3A1 protein co-treated with NADP] results in increased oxidation of benzaldehyde; Cimetidine inhibits the reaction [ALDH3A1 protein results in increased oxidation of benzaldehyde] ALDH3A1 protein results in increased metabolism of benzaldehyde
benzaldehyde results in increased activity of SLC2A1 protein [benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein
Benzoic Acid analog results in decreased activity of ACP1 protein Benzoic Acid analog inhibits the reaction [ACP1 protein results in increased hydrolysis of nitrophenylphosphate]
BCHE protein mutant form results in increased abundance of Benzoic Acid BCHE protein mutant form results in increased chemical synthesis of Benzoic Acid [BCHE protein mutant form results in increased metabolism of Cocaine] which results in increased chemical synthesis of Benzoic Acid [BCHE protein mutant form results in increased hydrolysis of Cocaine] which results in increased abundance of Benzoic Acid
Benzoic Acid analog results in decreased activity of [CCND1 protein binds to CDK4 protein] Benzoic Acid analog results in decreased expression of CCND1 protein
[Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated with prochloraz co-treated with propiconazole co-treated with tebuconazole] results in increased expression of CYP3A4 protein
Benzoic Acid analog inhibits the reaction [EGF protein promotes the reaction [STAT3 protein binds to EGFR protein]]; Benzoic Acid analog inhibits the reaction [EGF protein results in increased phosphorylation of STAT3 protein]
Benzoic Acid analog inhibits the reaction [Adenosine Diphosphate results in increased phosphorylation of EPHA4 protein]; Benzoic Acid analog inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY results in increased phosphorylation of EPHA4 protein]
[MYC protein results in increased expression of SLC16A1 protein] which results in increased import of Benzoic Acid Benzoic Acid analog results in decreased expression of MYC protein
Benzoic Acid inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid] Benzoic Acid results in decreased activity of PTGS2 protein
Benzoic Acid analog inhibits the reaction [PTPN1 protein results in increased hydrolysis of nitrophenylphosphate] Benzoic Acid analog results in decreased activity of PTPN1 protein
Benzoic Acid analog inhibits the reaction [PTPN2 protein results in increased hydrolysis of nitrophenylphosphate] Benzoic Acid analog results in decreased activity of PTPN2 protein
[MYC protein results in increased expression of SLC16A1 protein] which results in increased import of Benzoic Acid; Benzoic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid]; morin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid]; naringenin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid]; Quercetin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid]; silybin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] SLC16A1 protein results in increased transport of Benzoic Acid SLC16A1 protein results in increased import of Benzoic Acid SLC16A1 protein results in increased export of Benzoic Acid Acetic Acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid]; Butyric Acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid]; Foscarnet inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid]; mandelic acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid]; propionic acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid]; Protons inhibits the reaction [SLC16A1 protein results in increased export of Benzoic Acid]; Protons promotes the reaction [SLC16A1 protein results in increased import of Benzoic Acid]; Salicylic Acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid]
[Orotic Acid co-treated with Benzoic Acid] promotes the reaction [SLC22A7 protein results in increased export of Orotic Acid]; Benzoic Acid promotes the reaction [SLC22A7 protein results in increased export of Orotic Acid]
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [SLC4A2 protein results in increased uptake of Benzoic Acid]; Bicarbonates inhibits the reaction [SLC4A2 protein results in increased uptake of Benzoic Acid]; Chlorides inhibits the reaction [SLC4A2 protein results in increased uptake of Benzoic Acid]
Benzoic Acid analog inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]; Benzoic Acid analog inhibits the reaction [STAT3 protein binds to BCL2 promoter]; Benzoic Acid analog inhibits the reaction [STAT3 protein binds to BIRC5 promoter]; Benzoic Acid analog inhibits the reaction [STAT3 protein binds to NOS2 promoter]; Benzoic Acid analog results in decreased phosphorylation of and results in decreased activity of STAT3 protein Benzoic Acid analog inhibits the reaction [EGF protein promotes the reaction [STAT3 protein binds to EGFR protein]]; Benzoic Acid analog inhibits the reaction [EGF protein results in increased phosphorylation of STAT3 protein]; Benzoic Acid analog results in decreased phosphorylation of and results in decreased activity of STAT3 protein
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole results in increased expression of ATF4 mRNA 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of ATF4 mRNA]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitric Oxide results in increased nitrosation of and results in decreased degradation of BCL2 protein]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole results in decreased nitrosation of and results in increased ubiquitination of and results in increased degradation of BCL2 protein; [1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole results in decreased nitrosation of and results in increased ubiquitination of and results in increased degradation of BCL2 protein] which results in increased susceptibility to Chromates
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in decreased expression of BIRC5 protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Bortezomib results in increased cleavage of CASP3 protein]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Chloroquine results in increased cleavage of CASP3 protein]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased cleavage of CASP3 protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in decreased expression of CCND1 protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [CD28 protein results in increased abundance of Calcium]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [CD28 protein results in increased abundance of Nitric Oxide]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [CD28 protein results in increased abundance of Reactive Oxygen Species]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in increased expression of CDH1 protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased expression of CEBPB protein alternative form] 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of CEBPB protein alternative form]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased expression of CEBPB protein alternative form]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [9,10-phenanthrenequinone results in decreased expression of CLDN5 protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in decreased expression of and results in increased phosphorylation of CTNNB1 protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole results in increased expression of DDIT3 mRNA 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased expression of DDIT3 protein] 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased expression of DDIT3 protein]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of DDIT3 mRNA]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in decreased phosphorylation of GSK3B protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in decreased expression of MYC protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in decreased expression of SNAI1 protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in decreased expression of SNAI2 protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole results in decreased susceptibility to TNFSF10 protein 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [TNFSF10 protein results in increased abundance of Reactive Nitrogen Species]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of TRIB3 protein]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitroprusside results in increased expression of TRIB3 protein]
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in decreased expression of VIM protein]
galangin results in increased expression of ABCB1 mRNA; galangin results in increased expression of ABCB1 protein galangin results in increased activity of ABCB1 protein galangin inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]]; Verapamil promotes the reaction [galangin results in increased activity of ABCB1 protein]
galangin results in increased activity of AHR protein galangin affects the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; galangin binds to and results in decreased activity of AHR protein; galangin binds to and results in increased activity of AHR protein; galangin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the localization of AHR protein]; galangin inhibits the reaction [Benzo(a)pyrene affects the localization of AHR protein]; galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of AHR mRNA]; galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of AHR protein]; galangin inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of AHR protein]; galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of AHR protein] galangin affects the localization of AHR protein
galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of ARNT mRNA]; galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of ARNT protein]
galangin results in increased expression of ATG12 mRNA; galangin results in increased expression of ATG12 protein [ATG12 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; LY2109761 inhibits the reaction [galangin results in increased expression of ATG12 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of ATG12 protein]
[ATG16L1 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; LY2109761 inhibits the reaction [galangin results in increased expression of ATG16L1 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of ATG16L1 protein] galangin results in increased expression of ATG16L1 mRNA; galangin results in increased expression of ATG16L1 protein
[ATG3 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; LY2109761 inhibits the reaction [galangin results in increased expression of ATG3 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of ATG3 protein] galangin results in increased expression of ATG3 mRNA; galangin results in increased expression of ATG3 protein
[BECN1 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; LY2109761 inhibits the reaction [galangin results in increased expression of BECN1 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of BECN1 protein] galangin results in increased expression of BECN1 mRNA; galangin results in increased expression of BECN1 protein
galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased activity of CASP1 protein] galangin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of and results in increased activity of CASP1 protein]
[ATG12 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; [ATG16L1 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; [ATG3 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; [BECN1 mutant form co-treated with galangin] results in decreased activity of CASP3 protein galangin results in increased cleavage of CASP3 protein
galangin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased activity of CAT protein] galangin inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein]
galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] galangin results in increased expression of CYP1A1 mRNA galangin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein] galangin results in decreased activity of CYP1A1 protein
galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] galangin results in decreased activity of CYP1A2 protein
galangin binds to and results in decreased activity of CYP1B1 protein galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]
galangin results in increased expression of CYP3A4 mRNA [[galangin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [galangin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; galangin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; galangin promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam] galangin results in decreased activity of CYP3A4 protein
galangin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; galangin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein]
ferrous sulfate inhibits the reaction [galangin results in increased expression of EPAS1 protein]; Iron inhibits the reaction [galangin results in increased expression of EPAS1 protein]
ferrous sulfate inhibits the reaction [galangin results in increased expression of HIF1A protein]; galangin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; galangin promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Iron inhibits the reaction [galangin results in increased expression of HIF1A protein]
[Cadmium co-treated with galangin] results in increased expression of HMOX1 protein; galangin inhibits the reaction [Doxorubicin results in decreased expression of HMOX1 protein]
galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA] galangin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1B protein]; galangin inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]
galangin inhibits the reaction [Doxorubicin results in increased expression of IL6 protein]; galangin inhibits the reaction [Fructose results in increased expression of IL6 protein] galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]
galangin promotes the reaction [NCOA1 protein binds to NR1I2 protein] galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of NCOA1 mRNA]
galangin results in decreased expression of NFE2L2 protein [Cadmium co-treated with galangin] results in increased expression of NFE2L2 protein; galangin inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]
galangin inhibits the reaction [Doxorubicin results in increased expression of NOS2 protein] galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 mRNA]
[Cadmium co-treated with galangin] results in increased expression of NQO1 protein galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]
galangin binds to and results in increased activity of NR1I2 protein; galangin promotes the reaction [NCOA1 protein binds to NR1I2 protein]; galangin promotes the reaction [NCOA2 protein binds to NR1I2 protein]; galangin promotes the reaction [NCOA3 protein binds to NR1I2 protein] galangin results in increased activity of NR1I2 protein
galangin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which affects the localization of RELA protein]; galangin inhibits the reaction [Doxorubicin results in increased expression of RELA protein modified form]; galangin inhibits the reaction [Fructose affects the localization of RELA protein] galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]
galangin results in increased expression of SMAD1 mRNA LY2109761 inhibits the reaction [galangin results in increased phosphorylation of SMAD1 protein]
galangin results in increased expression of SMAD2 mRNA LY2109761 inhibits the reaction [galangin results in increased phosphorylation of SMAD2 protein]
galangin results in increased expression of SMAD3 mRNA LY2109761 inhibits the reaction [galangin results in increased phosphorylation of SMAD3 protein]
SMAD4 mutant form inhibits the reaction [galangin results in increased expression of ATG12 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of ATG16L1 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of ATG3 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of BECN1 protein] galangin results in increased expression of SMAD4 mRNA
galangin inhibits the reaction [Fructose results in increased expression of TGFB1 protein] galangin inhibits the reaction [Benzo(a)pyrene results in increased expression of TGFB1 mRNA]
galangin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TNF protein]; galangin inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; galangin inhibits the reaction [Fructose results in increased expression of TNF mRNA]; galangin inhibits the reaction [Fructose results in increased expression of TNF protein] galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; galangin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; galangin inhibits the reaction [TNF protein results in increased expression of SELE protein]
Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA] Orlistat results in decreased expression of ACACA mRNA
orlistat inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in decreased expression of PTEN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Malondialdehyde]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Triglycerides]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CCND1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CD34 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of FASN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of IL6 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PCNA protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PTGS2 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of SREBF1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of TNF protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK3 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of RPS6 protein]
[1,1,1,2,2-pentafluoro-7-phenylheptan-3-one co-treated with Orlistat] inhibits the reaction [APP protein modified form results in increased secretion of Arachidonic Acid]
orlistat results in increased activity of CASP3 protein orlistat results in increased cleavage of CASP3 protein Orlistat inhibits the reaction [Dietary Fats results in increased expression of CASP3 mRNA]
orlistat analog results in increased cleavage of and results in increased activity of CASP8 protein; orlistat results in increased cleavage of and results in increased activity of CASP8 protein Orlistat inhibits the reaction [Dietary Fats results in increased expression of CASP8 mRNA]
Orlistat inhibits the reaction [Dietary Fats results in decreased activity of CAT protein]; Orlistat inhibits the reaction [Dietary Fats results in decreased expression of CAT mRNA]; Orlistat inhibits the reaction [Dietary Fats results in decreased expression of CAT protein] Orlistat results in decreased expression of CAT protein
[[orlistat results in decreased abundance of Fatty Acids, Nonesterified] which results in decreased secretion of CCK protein] which results in decreased secretion of PNLIP protein; orlistat inhibits the reaction [Fats results in increased secretion of CCK protein]; orlistat inhibits the reaction [Olive Oil results in increased secretion of CCK protein] orlistat results in decreased secretion of CCK protein
Orlistat results in increased expression of CCND1 protein Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CCND1 protein]
Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]
orlistat results in increased phosphorylation of EIF2A protein orlistat analog results in increased phosphorylation of EIF2A protein; orlistat results in increased phosphorylation of EIF2A protein Cycloheximide inhibits the reaction [orlistat results in increased phosphorylation of EIF2A protein] orlistat promotes the reaction [EIF2AK3 protein results in increased phosphorylation of EIF2A protein]
EIF2AK3 gene mutant form results in increased susceptibility to orlistat orlistat promotes the reaction [EIF2AK3 protein results in increased phosphorylation of EIF2A protein]
ERBB2 protein affects the susceptibility to orlistat orlistat results in decreased expression of ERBB2 mRNA; orlistat results in decreased expression of ERBB2 protein orlistat affects the localization of ERBB2 protein
orlistat analog binds to FASN protein FASN protein affects the susceptibility to orlistat [Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Fatty Acids; [Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphatidylcholines; [Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine; [Orlistat results in decreased activity of FASN protein] which results in decreased chemical synthesis of Fatty Acids; [Orlistat results in decreased activity of FASN protein] which results in decreased expression of SKP2 protein; Orlistat binds to and results in decreased activity of FASN protein; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of FASN protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Doxorubicin]; Orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Mitoxantrone] orlistat analog results in decreased activity of FASN protein; orlistat results in decreased activity of FASN protein [orlistat results in decreased activity of FASN protein] which affects the abundance of Fatty Acids, Nonesterified; orlistat inhibits the reaction [FASN protein results in increased chemical synthesis of Palmitic Acid] Orlistat results in decreased expression of FASN protein
orlistat inhibits the reaction [Dietary Fats results in increased secretion of GCG protein]; orlistat inhibits the reaction [Olive Oil results in increased secretion of GCG protein] orlistat results in decreased expression of GCG protein orlistat results in decreased secretion of GCG protein
orlistat inhibits the reaction [Olive Oil results in decreased expression of GHRL protein]; orlistat inhibits the reaction [Triglycerides results in decreased secretion of GHRL protein]
orlistat inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein]
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of IL6 protein]; Orlistat inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] Orlistat inhibits the reaction [Dietary Fats results in increased expression of IL6 protein]
orlistat results in decreased expression of INS protein orlistat results in increased expression of INS protein orlistat affects the expression of INS protein [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]; Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]
orlistat results in decreased activity of LPL protein orlistat inhibits the reaction [Dietary Fats results in decreased expression of LPL protein] orlistat inhibits the reaction [[LPL protein results in increased hydrolysis of Triglycerides] which results in increased uptake of Triglycerides]; orlistat inhibits the reaction [LPL protein results in decreased activity of TNF protein]; orlistat inhibits the reaction [very low density lipoprotein triglyceride results in increased activity of LPL protein] [orlistat results in decreased activity of LPL protein] which affects the uptake of Triglycerides
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in decreased expression of PTEN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Malondialdehyde]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Triglycerides]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CCND1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CD34 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of FASN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of IL6 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PCNA protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PTGS2 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of SREBF1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of TNF protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK3 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of RPS6 protein]
Orlistat inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 mRNA] [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA
Orlistat inhibits the reaction [Dietary Fats results in increased expression of NOS2 mRNA]; Orlistat inhibits the reaction [Dietary Fats results in increased expression of NOS2 protein]
Orlistat inhibits the reaction [Fats results in increased secretion of NTS protein]; Orlistat inhibits the reaction [Olive Oil results in increased secretion of NTS protein]
orlistat results in decreased activity of PLA2G7 protein [orlistat co-treated with Ezetimibe] results in decreased activity of PLA2G7 protein; [orlistat co-treated with Fenofibrate] results in decreased activity of PLA2G7 protein
orlistat results in decreased secretion of PNLIP protein orlistat results in decreased activity of PNLIP protein orlistat inhibits the reaction [Taurocholic Acid results in increased activity of PNLIP protein] orlistat affects the folding of PNLIP protein [[orlistat results in decreased abundance of Fatty Acids, Nonesterified] which results in decreased secretion of CCK protein] which results in decreased secretion of PNLIP protein; orlistat inhibits the reaction [[PNLIP protein co-treated with CLPS protein] results in increased hydrolysis of Olive Oil]
Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]
orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] orlistat inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein]
Orlistat results in increased expression of PTEN protein Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in decreased expression of PTEN protein]
orlistat results in decreased secretion of PYY protein orlistat inhibits the reaction [Olive Oil results in increased expression of PYY protein]; orlistat inhibits the reaction [Triglycerides results in increased secretion of PYY protein]
[orlistat results in decreased activity of FASN protein] which results in decreased expression of SKP2 protein orlistat results in decreased expression of SKP2 protein
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of SREBF1 protein] Orlistat results in decreased expression of SREBF1 protein
[Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]; Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]
[Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of TNF protein]; Orlistat inhibits the reaction [LPL protein results in decreased activity of TNF protein] Orlistat inhibits the reaction [Dietary Fats results in increased expression of TNF mRNA] Orlistat inhibits the reaction [Dietary Fats results in increased expression of TNF protein]
Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]
Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased activity of ACHE protein]; Coconut Oil affects the reaction [Sodium Benzoate results in increased expression of ACHE mRNA] Sodium Benzoate results in increased expression of ACHE protein
Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]
Sodium Benzoate results in decreased expression of AR mRNA [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Sodium Benzoate results in decreased expression of AR mRNA]
Sodium Benzoate results in increased expression of BCL2L11 protein 3-(4-methylphenylsulfonyl)-2-propenenitrile affects the reaction [Sodium Benzoate results in increased expression of BCL2L11 protein]
3-(4-methylphenylsulfonyl)-2-propenenitrile affects the reaction [Sodium Benzoate results in increased activity of CASP3 protein]; Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP3 protein] Sodium Benzoate results in increased expression of CASP3 protein [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Sodium Benzoate results in increased expression of CASP3 protein]; Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased expression of CASP3 protein]
Sodium Benzoate results in decreased activity of CAT protein Sodium Benzoate results in decreased expression of CAT protein [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Sodium Benzoate results in decreased activity of CAT protein]; [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Sodium Benzoate results in decreased expression of CAT protein]; Ascorbic Acid inhibits the reaction [Sodium Benzoate results in decreased activity of CAT protein]; Coconut Oil inhibits the reaction [Sodium Benzoate results in decreased expression of CAT protein]
Sodium Benzoate inhibits the reaction [Adenine results in increased expression of CCL2 mRNA] Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Sodium Benzoate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Sodium Benzoate results in increased expression of CNTF protein]; Sodium Benzoate results in increased expression of and results in increased secretion of CNTF protein CREB1 affects the reaction [Sodium Benzoate results in increased expression of CNTF protein]; Sodium Benzoate promotes the reaction [CREB1 protein binds to CNTF promoter]; Sodium Benzoate promotes the reaction [CREBBP protein binds to CNTF promoter] Sodium Benzoate results in increased expression of CNTF mRNA
CREB1 protein promotes the reaction [Sodium Benzoate results in increased expression of GDNF mRNA] Sodium Benzoate results in increased phosphorylation of CREB1 protein CREB1 affects the reaction [Sodium Benzoate results in increased expression of CNTF protein]; CREB1 protein promotes the reaction [Sodium Benzoate results in increased expression of GDNF mRNA]; CREB1 protein promotes the reaction [Sodium Benzoate results in increased expression of TH protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Sodium Benzoate results in increased phosphorylation of CREB1 protein]; Sodium Benzoate promotes the reaction [CREB1 protein binds to CNTF promoter]
Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]
Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA] Sodium Benzoate results in decreased activity of DAO protein
Sodium Benzoate results in increased expression of GDNF mRNA; Sodium Benzoate results in increased expression of GDNF protein CREB1 protein promotes the reaction [Sodium Benzoate results in increased expression of GDNF mRNA] CREB1 protein promotes the reaction [Sodium Benzoate results in increased expression of GDNF mRNA]; GDNF protein promotes the reaction [Sodium Benzoate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein]]; Sodium Benzoate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF protein]
Sodium Benzoate results in decreased expression of HMOX1 protein [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Sodium Benzoate results in decreased expression of HMOX1 protein]
HNMT gene SNP affects the susceptibility to [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with azo rubin S co-treated with quinoline yellow co-treated with Allura Red AC Dye co-treated with Sodium Benzoate]; HNMT gene SNP affects the susceptibility to [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with azo rubin S co-treated with Tartrazine co-treated with ponceau 4R co-treated with Sodium Benzoate]
[Fructose co-treated with Sodium Benzoate] results in increased expression of IFNG protein; Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein] Sodium Benzoate affects the expression of IFNG mRNA [Sodium Benzoate co-treated with MBP protein] results in decreased expression of IFNG mRNA; [Sodium Benzoate co-treated with MBP protein] results in decreased expression of IFNG protein [Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IFNG mRNA
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL10 mRNA Sodium Benzoate affects the expression of IL10 mRNA
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL1B mRNA; [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Sodium Benzoate results in increased expression of IL1B protein]; Coconut Oil inhibits the reaction [Sodium Benzoate results in increased expression of IL1B protein] Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Sodium Benzoate inhibits the reaction [TNF protein results in increased expression of IL1B mRNA] Sodium Benzoate inhibits the reaction [Adenine results in increased expression of IL1B mRNA]
[Sodium Benzoate co-treated with MBP protein] results in increased expression of IL4 mRNA; [Sodium Benzoate co-treated with MBP protein] results in increased expression of IL4 protein
Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] [Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL6 mRNA Sodium Benzoate results in increased expression of IL6 protein
[Sodium Benzoate co-treated with Sorbic Acid] results in increased expression of MAPK8 mRNA; Sodium Benzoate inhibits the reaction [Adenine results in increased phosphorylation of MAPK8 protein]; Sodium Benzoate inhibits the reaction [amyloid beta-protein (1-42) results in increased phosphorylation of MAPK8 protein] Sodium Benzoate results in decreased expression of MAPK8 mRNA Sodium Benzoate promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein]
[Sodium Benzoate co-treated with MBP protein] results in decreased expression of IFNG mRNA; [Sodium Benzoate co-treated with MBP protein] results in decreased expression of IFNG protein; [Sodium Benzoate co-treated with MBP protein] results in increased expression of IL4 mRNA; [Sodium Benzoate co-treated with MBP protein] results in increased expression of IL4 protein
Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form]; Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA]
Sodium Benzoate results in decreased expression of NFE2L2 mRNA; Sodium Benzoate results in decreased expression of NFE2L2 protein [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Sodium Benzoate results in decreased expression of NFE2L2 mRNA]; [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Sodium Benzoate results in decreased expression of NFE2L2 protein]; Coconut Oil inhibits the reaction [Sodium Benzoate results in decreased expression of NFE2L2 mRNA]
Sodium Benzoate results in increased expression of NFKB1 mRNA; Sodium Benzoate results in increased expression of NFKB1 protein [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Sodium Benzoate results in increased expression of NFKB1 protein]; Coconut Oil affects the reaction [Sodium Benzoate results in increased expression of NFKB1 mRNA]
Sodium Benzoate affects the reaction [OTC gene mutant form affects the abundance of Hydroxyindoleacetic Acid]; Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Glycine]; Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Serotonin]; Sodium Benzoate affects the reaction [OTC gene mutant form results in increased abundance of Ammonium Compounds]
Sodium Benzoate inhibits the reaction [Adenine results in increased phosphorylation of RELA protein] Sodium Benzoate affects the localization of RELA protein 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Sodium Benzoate affects the localization of RELA protein]
Sodium Benzoate inhibits the reaction [Adenine results in increased expression of RELB mRNA]; Sodium Benzoate inhibits the reaction [Adenine results in increased expression of RELB protein] Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased expression of RELB mRNA]; Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased expression of RELB protein]; Sodium Benzoate inhibits the reaction [TNF protein results in increased expression of RELB mRNA]
SLC6A3 gene SNP affects the susceptibility to [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with azo rubin S co-treated with quinoline yellow co-treated with Allura Red AC Dye co-treated with Sodium Benzoate]; SLC6A3 gene SNP affects the susceptibility to [6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with azo rubin S co-treated with Tartrazine co-treated with ponceau 4R co-treated with Sodium Benzoate]
Sodium Benzoate promotes the reaction [STAT6 protein binds to TGFB1 promoter]; Sodium Benzoate results in increased phosphorylation of and affects the localization of STAT6 protein
Sodium Benzoate results in increased expression of TGFB1 mRNA Sodium Benzoate affects the expression of TGFB1 mRNA Sodium Benzoate inhibits the reaction [Adenine results in increased expression of TGFB1 mRNA]; Sodium Benzoate promotes the reaction [STAT6 protein binds to TGFB1 promoter]; Sodium Benzoate results in increased expression of and results in increased secretion of TGFB1 protein
Sodium Benzoate results in increased expression of TH mRNA; Sodium Benzoate results in increased expression of TH protein CREB1 protein promotes the reaction [Sodium Benzoate results in increased expression of TH protein]; GDNF protein promotes the reaction [Sodium Benzoate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein]]; Sodium Benzoate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein]
[Fructose co-treated with Sodium Benzoate] results in increased expression of TNF protein; Sodium Benzoate inhibits the reaction [Adenine results in increased expression of TNF mRNA]; Sodium Benzoate inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of TNF protein]; Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Sodium Benzoate affects the expression of TNF mRNA Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Sodium Benzoate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; Sodium Benzoate inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]; Sodium Benzoate inhibits the reaction [TNF protein results in increased expression of RELB mRNA]; Sodium Benzoate inhibits the reaction [TNF protein results in increased expression of TNF mRNA] [Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of TNF mRNA; [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Sodium Benzoate results in increased expression of TNF protein]; Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased expression of TNF protein] Sodium Benzoate results in increased expression of TNF mRNA; Sodium Benzoate results in increased expression of TNF protein
Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA] Sodium Benzoate results in increased expression of TP53 protein
browse the term
